HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Henkel

This article was originally published in The Rose Sheet

Executive Summary

German consumer goods firm sells Cognis chemical products division to further develop core businesses in transaction valued at $2.35 bil. ([Euro]1=$.90), Henkel announces. Consortium of financial investors comprising Schroder Ventures and Goldman Sachs acquired the chemical division that served manufacturers of cosmetics, cleaners and detergents. Cognis business, which includes Oleochemicals, Care Chemicals and Organic Specialties, generated sales of $2.9 bil. in 2000 and represented 23% of Henkel sales. Agreement was signed Sept. 12 and is expected to close in November. Henkel announced it would consider selling Cognis to focus on Cosmetics/Toiletries, Laundry & Home Care and Adhesives last year (1"The Rose Sheet" Nov. 20, 2000, p. 7)

You may also be interested in...



Henkel Cosmetics Business Eyes Top Five Worldwide Ranking - CEO

Henkel plans to build its cosmetics segment to become one of the top five businesses in the world, CEO Ulrich Lehner maintained during an analyst meeting Nov. 13.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

UsernamePublicRestriction

Register

LL1128165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel